{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:27:29Z","timestamp":1788550049765,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtha.2024.07.019","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T09:46:23Z","timestamp":1725183983000},"page":"3125-3136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-7287","authenticated-orcid":false,"given":"Simon","family":"Kraler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Nopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Englisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Grilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Lapikova-Bryhinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Akhmedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ramoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Tirandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Scuricini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Isoppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curzia","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Michelauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Fr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Gavoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Suter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian A.","family":"Wenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7738-4119","authenticated-orcid":false,"given":"Florian","family":"Moik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.07.019_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.07.019_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaccao.2022.01.102","article-title":"Does cardiovascular mortality overtake cancer mortality during cancer survivorship?: an English retrospective cohort study","volume":"4","author":"Strongman","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident cardiovascular disease among adults with cancer: a population-based cohort study","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib5","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.019_bib6","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.jacc.2020.03.067","article-title":"Mechanistic biomarkers informative of both cancer and cardiovascular disease: JACC state-of-the-art review","volume":"75","author":"Narayan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.07.019_bib7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.019_bib8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","article-title":"Myocardial infarction accelerates breast cancer via innate immune reprogramming","volume":"26","author":"Koelwyn","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2024.07.019_bib9","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","article-title":"Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2024.07.019_bib10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.07.019_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.07.019_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13424","article-title":"Repurposing colchicine to combat residual cardiovascular risk: the LoDoCo2 trial","volume":"50","author":"Kraler","year":"2020","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jtha.2024.07.019_bib13","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehz460","article-title":"Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study","volume":"40","author":"Abdel-Qadir","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.019_bib14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jtha.2024.07.019_bib15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.019_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/eurjpc\/zwaa034","article-title":"Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry","volume":"29","author":"Caro-Cod\u00f3n","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jtha.2024.07.019_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaccao.2021.02.007","article-title":"Arterial thromboembolism in cancer patients: a Danish population-based cohort study","volume":"3","author":"Mulder","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib18","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.thromres.2022.01.004","article-title":"Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies","volume":"213","author":"Moik","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.019_bib19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jtha.2023.04.043","article-title":"Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study","volume":"21","author":"Nopp","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.019_bib20","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A\u00a0clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2024.07.019_bib21","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/ATVBAHA.121.316463","article-title":"Hemostatic biomarkers and venous thromboembolism are associated with mortality and response to chemotherapy in patients with pancreatic cancer","volume":"41","author":"Moik","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.07.019_bib22","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D-dimer and prothrombin fragment 1\u00a0+ 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.07.019_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2024.07.019_bib25","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/eurheartj\/ehac143","article-title":"Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.019_bib26","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/eurheartj\/ehab081","article-title":"Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study","volume":"42","author":"Arnold","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.019_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.12.023","article-title":"Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function","volume":"231","author":"Quercioli","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2024.07.019_bib28","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/cancers12061619","article-title":"Systemic inflammation and activation of haemostasis predict poor prognosis and response to chemotherapy in patients with advanced lung cancer","volume":"12","author":"Moik","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtha.2024.07.019_bib29","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.07.019_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/STROKEAHA.109.572883","article-title":"What is a minor stroke?","volume":"41","author":"Fischer","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.07.019_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2125.1996.tb00162.x","article-title":"Analysing survival data from clinical trials and Observational Studies; E. Marubini & M. G. Valsecchi Published by John Wiley & Sons 414 pages ISBN 0-971-93987-0","volume":"41","author":"Marubini","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2024.07.019_bib32","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jtha.2024.07.019_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2024.07.019_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection - a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J"},{"key":"10.1016\/j.jtha.2024.07.019_bib35","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1161\/CIRCULATIONAHA.121.055393","article-title":"Recommendations for statistical reporting in cardiovascular medicine: a special report from the American Heart Association","volume":"144","author":"Althouse","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.019_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2023.05.014","article-title":"Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: a case-cohort analysis","volume":"376","author":"Kraler","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2024.07.019_bib37","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.07.019_bib38","series-title":"Statistical methods for survival data analysis","author":"Lee","year":"2003"},{"key":"10.1016\/j.jtha.2024.07.019_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","article-title":"Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2024.07.019_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.019_bib41","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/eurheartj\/ehab171","article-title":"Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis","volume":"42","author":"Grilz","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.019_bib42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3324\/haematol.2018.192419","article-title":"Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer","volume":"103","author":"Grilz","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.07.019_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaccao.2022.05.002","article-title":"Major adverse cardiovascular events in patients with renal cell carcinoma treated with targeted therapies","volume":"4","author":"Chen","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchf.2012.09.001","article-title":"The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients","volume":"1","author":"Hall","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jtha.2024.07.019_bib45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11060-013-1341-x","article-title":"Comorbid conditions associated with glioblastoma","volume":"116","author":"Fisher","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.jtha.2024.07.019_bib46","article-title":"Raised cardiovascular disease mortality after central nervous system tumor diagnosis: analysis of 171,926 patients from UK and USA","volume":"3","author":"Jin","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jtha.2024.07.019_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11936-020-00866-2","article-title":"Vascular endothelial growth factor (VEGF) inhibitor cardiotoxicity: what should we know?","volume":"22","author":"L\u00f3pez-Fern\u00e1ndez","year":"2020","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.07.019_bib48","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality","volume":"101","author":"Pavo","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2024.07.019_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/glycob\/cwx105","article-title":"Selectins in cancer immunity","volume":"28","author":"Borsig","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.jtha.2024.07.019_bib50","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/jth.14484","article-title":"Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer","volume":"17","author":"Grilz","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.019_bib51","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3389\/fimmu.2019.01321","article-title":"L-selectin enhanced T cells improve the efficacy of cancer immunotherapy","volume":"10","author":"Watson","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.07.019_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(03)00280-6","article-title":"Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME study","volume":"170","author":"Luc","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2024.07.019_bib53","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.019_bib54","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1177\/2047487320938271","article-title":"Use of lipoprotein(a) for refining cardiovascular risk prediction in a low-risk population: the CoLaus\/PsyCoLaus study","volume":"28","author":"Delabays","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jtha.2024.07.019_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","article-title":"Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study","volume":"64","author":"Willeit","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T21:37:20Z","timestamp":1734557840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624004367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1538783624004367"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.019","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}